Friday, December 3, 2021
Home News Ingredients CII Continues to Produce Consistent High-Quality Food Particulates

CII Continues to Produce Consistent High-Quality Food Particulates

The Cereals Ingredients, Inc. (CII) is a privately held, employee-owned specialty ingredients manufacturer established to deliver food innovations. The company was formed in 1990 by Robert Hatch, and its philosophies are based on research, development, and marketing of unique food ingredients. 

CII produces food particulates that add flavor, color, and character to numerous food applications as well as pre-blended mixes to create flavored swirl effects in bread products. Its diverse portfolio also encompasses texturized plant-based proteins and crisps as well as clusters and granola.

The company holds multiple worldwide product and process patents. Its Flav-R-Bites® are specially formulated for specific client needs and offered in various sizes, flavors, and textures. The ingredient is also produced using CII’s patented product and process technology

Additionally, the company’s latest product line, Nutri-Bites® and Nutri-Crisps® are produced in a second Leavenworth facility that came online in June 2008. Direct expanded products consist of unique nutritional qualities protein, fiber, pulse grains, and minerals.

According to Scott Cowger, Vice President-National Sales Manager at CII, “Unlike most fat-based or sugar-based particles, our Flav-R-Bites and Nutri-Crisps stand up to heat, moisture, are shelf-stable, and after all, they make your products look and taste better!”

CII products are available in GMO, Non-GMO, gluten-free, and organic formulations. They are all certified for food purity certified Kosher/Parve and produced under the Islamic certification, Halal.

- Advertisment -

Most Popular

Gadot Biochemicals Announces Mineral Fortification Program for Plant-based Milk

Israel-based Gadot Biochemical Industries (GBI), a leading global dietary mineral supplier, has unveiled a new focus on plant-based milk fortification with its...

New Study Highlights Vit K2 Potential Combination for CKD Patients

A newly published animal model, supported by NattoPharma, shows the potential of inhibiting vascular calcification when combining Vitamin K2 with phosphate binders.

Nutrasource Joins NASC as Preferred Supplier

Nutrasource Pharmaceutical and Nutraceutical Services, a global full-service contract research organization (CRO), recently announced its membership into the NASC (National Animal Supplement...

Farlong Pharmaceutical Announces Three-Year Clinical Trial Determining the Effect of Farlong NotoGinseng™

Farlong Pharmaceutical, a vertically integrated, plant-based ingredient and supplement company, recently announced the publication of the results of their clinical trial titled “Randomized,...

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

- Advertisment -